Back to MW Marshall Wace, LLP
VKTX
Showing 6 of 14 quarters
Position history for MWMarshall Wace, LLP's holdings in Viking Therapeutics, Inc.
Yes. Marshall Wace holds 42,767 shares of VKTX (Viking Therapeutics), worth $1.7M, as of its Q2 2026 13F filing. It reduced the position by 47,593 shares (-52.7%) from Q1 2026. Marshall Wace has held VKTX since Q1 2026, across 2 quarterly 13F filings.
Current Value
$1.7M
Current Shares
42,767
Total Value Change
+$537,750
Total Shares Change
+24,909
Quarter-by-Quarter History